Osteonic Co (226400) Fair Value & Analysis
Healthcare · KR · Market cap 90.3B KRW
Fair value as of: Jul 20, 2026
From 23 valuation models · updated 21 days ago
Fair value updated Jul 20, 2026, revised from 5,001 KRW to 4,989 KRW (−0.2%) since Jul 7, 2026. Share price +12.0% over the past month.
Below-average quality, currently priced close to our fair value.
What matters now
- The model range is unusually wide (3,147 KRW to 9,443 KRW). The outcome hinges heavily on assumptions, so read the point estimate with caution.
- The price sits close to our fair value, market and models broadly agree here, little valuation tension.
Price vs Fair Value (5 years)
White line = price, green steps = our fair value per fiscal year, dashed = 300-day average. As of Jul 20, 2026.
How to read this chart
60‑month range 2,340 KRW – 8,390 KRW · fair‑value band 3,147 KRW – 9,443 KRW · the 5,040 KRW price screens above the 4,989 KRW fair value. Dashed = 300-day average. As of Jul 20, 2026.
Analysis
Osteonic Co (226400) currently trades at 5,040 KRW, while our model-based Fair Value estimate is 4,989 KRW, implying the stock looks roughly 1.0% fairly valued today. The Quality Score stands at 47/100 (below-average quality), in the Healthcare sector. Bear case: priced above our estimate, the market already discounts strong expectations. Bull case: above-average quality can justify a premium, the entry price still matters most (evidence: high).
Over the trailing twelve months, Osteonic Co generated revenue of 48.8B KRW at a net margin of 19.3%. Revenue grew 35.4% year over year. It earns a return on equity of 14.3%. Net debt stands at 3.4B KRW. Fundamentals as of Jul 20, 2026
Our scenario range runs from 3,147 KRW (bear case) to 9,443 KRW (bull case); at 5,040 KRW, the current price sits within that range. Bear and bull are the same models run on conservative and optimistic assumptions (margins, growth, valuation multiples), so a plausible valuation range, not a price target. The share trades about 38% below its 52-week high and 21% above its 52-week low, currently below its 200-day average. For context, the median of 10 Healthcare peers we cover trades at -26% fair-value upside, at -1%, 226400 screens cheaper than that median.
Fair Value models
Each model estimates fair value its own way; the Fair Value above is the evidence-weighted blend. Evidence (0–100) measures how completely this model’s inputs are available: well-fed models carry more weight in the blend. The spread across models is intentional, each one stresses a different value driver; dividend models, for instance, come out structurally low when payout is small.
All 23 models by family
Widest divergence: Growth Earnings (11,159 KRW) versus Growth DCF (603.68 KRW). Highest evidence: Growth DCF (80).
Notify me when 226400 reaches fair value
Free. You confirm by email (double opt-in) and can unsubscribe anytime in one click.
Key figures & financial health
More key figures
Figures from reported company fundamentals · as of Jul 20, 2026. TTM = trailing twelve months.
Quality Score breakdown
Of which business quality 49 · Market factors (momentum, volatility) 25
Non-valuation factor families (profitability, growth, cashflow, financial strength, momentum …), each academically grounded. Valuation itself sits in the Fair Value and is deliberately excluded here to avoid double-counting.
About the company
Osteonic Co., Ltd. develops, manufactures, and sells bone fixation systems. It offers CMF systems, including neuro plating systems, maxillofacial plating systems, mandible plating systems, IMF screws, power screw drivers, 90 angled screw driver, customized neuro 3D mesh, and mandible reconstruction plates under the OPTIMUS and Real FIT brand names; and …
Full company description
Osteonic Co., Ltd. develops, manufactures, and sells bone fixation systems. It offers CMF systems, including neuro plating systems, maxillofacial plating systems, mandible plating systems, IMF screws, power screw drivers, 90 angled screw driver, customized neuro 3D mesh, and mandible reconstruction plates under the OPTIMUS and Real FIT brand names; and biodegradable CMF plating systems under the BIOBSORB name. The company also provides products for trauma and extremities, which include hand plating, wrist plating, foot plating, and hallux valgus systems, as well as cannulated screws under the SIGNEX name. In addition, it offers dental products, such as mini screws, GBR systems, palatal plates, power drivers, and palatal expanders under the Optimus D name; veterinary systems; and sports medicines under the KINEX brand name. The company serves physicians and university hospitals. Osteonic Co., Ltd. was founded in 2012 and is based in Seoul, South Korea.
Company description, as reported by the company or data provider.
Revenue & earnings trend
FY2021 – FY2025 · reported fiscal years
Osteonic Co reported revenue of 45.4B KRW in FY2025 versus 15.6B KRW in FY2021, a compound +30.6%/yr. Reported net income was 7.5B KRW in FY2025.
Watch 226400: get an alert when its fair value changes →
Peer Group
Medical Devices · 352 stocks
How this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.
Valuation Multiples vs Medical Devices median · lower = cheaper
Snowflake
Five quick dimensions, each 0 to 100: VALUE (fair-value potential), FUTURE (revenue growth), PAST (return on equity), HEALTH (low debt), DIVIDEND (yield). Green = this stock, grey = typical sector peer.
Values & ESG
Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.
ESG scores are not available for this stock yet. Values and ESG data are contextual and can differ between providers.
Similar stocks
10 more Medical Devices stocks, each showing price versus our Fair Value estimate (as of Jul 20, 2026).
| Stock | Price | Fair Value | vs Fair Value |
|---|---|---|---|
| Abbott Laboratories, ABT | $100.68 | $74.79 | -26% |
| Stryker Corporation SYK | $316.44 | $186.28 | -41% |
| Medtronic plc MDT | $83.56 | $65.57 | -22% |
| Boston Scientific Corporation BSX | $43.04 | $38.44 | -11% |
| Edwards Lifesciences Corporation EW | $85.73 | $41.02 | -52% |
| Siemens Healthineers AG SHL | €34.59 | €33.87 | -2% |
| DexCom, Inc DXCM | $74.96 | $38.95 | -48% |
| Shenzhen Mindray Bio-Medical Electronics Co 300760 | ¥149.43 | ¥147.63 | -1% |
| Shanghai United Imaging Healthcare Co 688271 | ¥109.00 | ¥43.60 | -60% |
| Demant A/S DEMANT | kr 276.60 | kr 161.17 | -42% |
Compare Osteonic Co with another stock
Price, fair value, quality and upside side by side.
Explore undervalued stocks
More undervalued Healthcare stocks →
Frequently asked questions
Is Osteonic Co (226400) overvalued or undervalued?
What is the fair value of 226400?
What is the quality score of 226400?
What is the revenue of Osteonic Co (226400)?
What is the net profit margin of 226400?
How we calculate Fair Value
Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data, nothing guessed.
Track Osteonic Co and try Pro for 14 days
One email gets you 14 days of full Pro (review alerts, the 35,000+ stock screener, the diversification check) plus the monthly Top-25 report of the most undervalued quality stocks. No card, cancel anytime.
Zero risk: nothing is ever charged. After 14 days you decide whether to stay.